hypertension: Persistently high systemic arterial blood pressure. Based on multiple readings (blood pressure determination), hypertension is currently defined as when systolic pressure is consistently greater than 140 mm Hg or when diastolic pressure is consistently 90 mm Hg or more.
Pre-eclampsia superimposed on chronic hypertension
DOID EFO Endpoint Browser PheWeb
O15_PREECLAMPS_CHRONIC_HYPERT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
209 |
4. Check minimum number of eventsNone |
209 |
5. Include endpointsNone |
209 |
6. Filter based on genotype QC (FinnGen only) |
209 |
Control definitions (FinnGen only)
- Control exclude
- O15_OEDEM_PROTUR_HYPERT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- O10-O16
- Name in latin
- Hypertensio prae-existens cum proteinuria superposita
Similar endpoints
↥List of similar endpoints to
Pre-eclampsia superimposed on chronic hypertension
based on the number of shared cases.
Similar with more cases:
- Pre-eclampsia or eclampsia
- Pre-eclampsia or poor fetal growth
- Pregnancy hypertension
- Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
- Delivery, wide proxy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1336 | 1336 | - |
| Only index persons | 1325 | 1325 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | - |
| Only index persons | 0.05 | 0.05 | - |
| Median age at first event (years) | |||
| Whole population | - | 32.55 | - |
| Only index persons | - | 32.55 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 209 | 209 | - |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | - |
| Median age at first event (years) | 33.08 | 33.08 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 194
- Matched controls
- 1940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
O11
ICD-10 Finland
Pre-eclampsia superimposed on chronic hypertension
+∞
280.8
194
*
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
+∞
124.9
106
*
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
1583.9
99.2
88
*
I10
ICD-10 Finland
Essential (primary) hypertension
14.2
60.1
136
274
C07AG01
ATC
labetalol; systemic
235.0
52.8
52
*
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
+∞
52.5
48
*
205
Kela drug reimbursment
Chronic hypertension
17.5
35.6
58
46
C09AA02
ATC
enalapril; systemic
12.8
31.4
59
64
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
6.4
29.5
100
277
C08CA01
ATC
amlodipine; oral
8.3
28.5
71
126
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
6.3
26.2
84
210
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
+∞
25.6
24
*
C08CA05
ATC
nifedipine; systemic
16.5
24.6
40
30
O14.1
ICD-10 Finland
Severe pre-eclampsia
+∞
24.5
23
*
C07AB02
ATC
metoprolol; systemic
8.3
23.9
57
92
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
5.5
22.9
82
227
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
6.1
19.3
58
126
103
Kela drug reimbursment
Diabetes, insulin-treated
6.0
17.2
51
108
C07AB07
ATC
bisoprolol; oral
4.2
17.1
84
301
215
Kela drug reimbursment
Diabetes, non-insulin-treated
5.9
16.7
50
107
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
12.9
14.8
26
23
K85
ICPC
Elevated blood pressure
7.3
14.5
36
59
A10BA02
ATC
metformin; oral
4.8
14.2
52
138
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
3.9
13.5
65
223
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
3.3
13.4
94
432
C09CA01
ATC
losartan; oral
4.7
12.6
46
121
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
40.4
12.4
15
*
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
4.4
11.9
46
127
E66.01
ICD-10 Finland
Obesity due to excess calories
4.7
11.9
43
111
C09BA02
ATC
enalapril and diuretics; systemic
20.5
11.8
17
9
O10.9
ICD-10 Finland
Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium
+∞
11.6
11
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
9.8
11.1
22
25
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
2.9
11.0
93
468
C09DA03
ATC
valsartan and diuretics; oral
23.1
10.9
15
7
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
11.0
10.8
20
20
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
11.6
10.5
19
18
O10.1
ICD-10 Finland
Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium
+∞
10.5
10
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
5.9
10.4
29
56
C09AA05
ATC
ramipril; oral
5.2
10.0
31
68
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
4.9
9.9
33
78
B01AB05
ATC
enoxaparin; parenteral
3.2
9.9
61
246
SPAT1262
SPAT
Handing over of treatment supplies
4.6
9.8
35
89
T90
ICPC
Diabetes non-insulin dependent
4.6
9.7
34
85
C03AA03
ATC
hydrochlorothiazide; oral
9.8
9.3
18
20
E66.8
ICD-10 Finland
Other obesity
4.9
8.9
29
67
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
7.6
8.8
20
29
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
6.2
8.8
23
41
A10AE04
ATC
insulin glargine; parenteral
6.2
8.8
23
41
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
8.0
8.7
19
26
C09CA03
ATC
valsartan; oral
7.3
8.6
20
30
C09CA06
ATC
candesartan; oral
3.2
8.5
50
192
O16
ICD-10 Finland
Unspecified maternal hypertension
+∞
8.4
8
*
A10BJ06
ATC
semaglutide; parenteral
11.5
7.9
14
13
O60
ICD-10 Finland
Preterm labour and delivery
5.1
7.8
24
52
ZXD05
NOMESCO Finland
Urgent procedure
2.4
7.8
86
478
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
7.7
7.7
17
24
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
5.2
7.6
23
49
XMA22
NOMESCO Finland
General examination of pregnant woman
3.1
7.5
43
163
C09DA01
ATC
losartan and diuretics; oral
6.3
7.4
19
33
E66.00
ICD-10 Finland
Metabolic syndrome
6.3
7.4
19
33
6420X
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium
+∞
7.3
7
*
H3603, E103
ICD-10 Finland
NA
31.3
7.2
9
*
H04AA01
ATC
glucagon; nasal, parenteral
9.3
7.2
14
16
O82.0
ICD-10 Finland
Delivery by elective caesarean section
3.5
7.2
33
106
A10AE05
ATC
insulin detemir; parenteral
6.8
7.1
17
27
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
3.4
7.1
35
119
C09DA06
ATC
candesartan and diuretics; oral
8.0
7.0
15
20
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
6.1
7.0
18
32
W84
ICPC
Pregnancy high risk
4.0
6.9
27
75
J01DB01
ATC
cefalexin; oral
3.0
6.8
173
1417
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
12.9
6.7
11
9
T89
ICPC
Diabetes insulin dependent
5.9
6.5
17
31
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
11.6
6.4
11
10
WX320
NOMESCO Finland
Spinalanesthesy
2.6
6.4
51
236
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
27.7
6.3
8
*
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
5.3
6.2
18
37
A10BK03
ATC
empagliflozin; oral
6.4
6.1
15
25
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
3.1
6.1
34
125
Z32.1
ICD-10 Finland
Pregnancy confirmed
2.5
6.0
53
257
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012516) Albumin [Mass/volume] in Urine
95
249
6.16
37.12
5.6
2.8
mg/l
104.5
323.3
0.33
77
156
(3020682) Albumin/Creatinine [Ratio] in Urine
96
262
5.93
35.65
6.8
3.3
mg/mmol
31.1
4.2
1.75
78
160
(3009508) Creatinine [Moles/volume] in Urine
102
322
5.23
31.29
5.3
2.5
mmol/l
7.6
7.9
0.31
91
281
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
179
1449
2.64
5.95
7.1
3.8
mmol/mol
42.1
37.0
6.43
174
1400
(3032080) INR in Blood by Coagulation assay
69
390
2.15
5.93
3.5
4.6
inr
1.0
1.0
0.00
18
132
(3013826) Glucose [Moles/volume] in Serum or Plasma
115
791
2.01
5.74
5.6
3.5
mmol/l
7.2
6.1
3.38
104
711
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
97
635
1.98
5.51
8.1
4.8
mmol/l
1.2
1.2
0.54
84
548
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
68
395
2.07
5.37
2.0
1.7
mg/l
0.8
0.6
0.61
48
290
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
8
11.68
5.34
2.9
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
138
1029
2.00
5.29
2.9
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
40
195
2.30
4.85
3.7
2.8
mmol/l
0.9
0.8
0.47
40
185
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
21
4.95
4.58
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
68
423
1.90
4.29
2.4
2.4
ng/l
13.5
19.4
0.31
32
136
(3022948) Iron [Moles/volume] in Serum or Plasma
40
209
2.13
4.08
3.4
2.0
umol/l
12.5
14.6
1.31
40
196
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
37
190
2.15
3.94
2.4
2.8
ng/l
1753.0
366.9
0.65
31
159
(3019225) pH of Specimen
27
121
2.41
3.94
4.0
3.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
25
4.15
3.74
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
10
25
4.15
3.74
1.1
1.1
nmol/l
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
78
529
1.76
3.62
1.9
1.8
pmol/l
102.7
98.2
0.41
48
308
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
30
147
2.22
3.58
4.4
2.8
%
27.1
32.6
3.15
25
106
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
150
1231
1.77
3.41
8.0
6.3
u/l
74.6
71.5
0.61
142
1161
(3037467) Urinalysis macro (dipstick) panel - Urine
144
1169
1.75
3.39
5.0
3.4
—
—
—
0
0
(3013512) EKG study
51
310
1.85
3.37
3.8
2.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
39
218
1.97
3.31
1.1
1.2
iu/ml
95.1
169.6
1.06
18
97
(3018677) aPTT in Platelet poor plasma by Coagulation assay
31
160
2.10
3.26
2.7
1.8
s
29.1
29.6
0.24
31
155
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
185
1636
2.14
3.15
4.2
2.9
mmol/l
1.4
1.2
5.67
177
1571
(3026008) Bacteria identified in Urine by Culture
60
392
1.74
3.11
2.6
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
184
1626
2.10
3.11
12.5
7.2
ml/min/173m2
92.5
94.0
0.41
162
1313
(3044640) Blood type and Crossmatch panel - Blood
75
527
1.66
2.96
3.3
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
22
4.23
2.91
1.2
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
191
1723
2.26
2.87
5.2
3.4
mmol/l
3.0
2.9
0.02
181
1666
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
189
1701
2.16
2.81
4.7
3.2
mmol/l
1.3
1.6
14.30
180
1648
(3030467) Casts [#/volume] in Urine by Automated count
52
338
1.72
2.72
3.9
2.2
e6/l
0.1
0.2
0.95
33
247
(3000991) Gas panel - Venous blood
14
55
2.66
2.67
19.3
5.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
189
1708
2.11
2.66
4.8
3.2
mmol/l
4.7
4.9
1.80
181
1657
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
15
4.79
2.62
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
77
562
1.59
2.54
1.7
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
16
4.49
2.49
1.0
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
12
5.11
2.42
3.3
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
40
2.85
2.41
3.3
3.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
56
383
1.63
2.40
3.3
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
8
6.37
2.38
5.6
5.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
17
4.22
2.38
3.7
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
66
471
1.59
2.37
1.7
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
95
740
1.52
2.30
2.5
2.2
nmol/l
68.9
74.2
1.25
90
707
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
18
3.99
2.27
2.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
18
3.99
2.27
2.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
18
3.99
2.27
2.0
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
199
1857
2.50
2.21
16.7
9.2
umol/l
68.8
65.0
0.77
199
1857
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
14
4.38
2.16
1.0
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
31
186
1.78
2.12
3.0
1.9
e6/l
1.5
1.1
0.32
16
91
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
267
1.67
2.11
1.9
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
101
810
1.48
2.06
4.3
3.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
51
356
1.57
1.99
3.9
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
114
1.94
1.95
3.0
4.3
%
1.7
1.1
0.27
12
32
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
33
2.80
1.95
1.7
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
11
4.63
1.95
6.6
1.5
%
61.6
65.5
—
5
11
(3041096) Erythrocytes [Presence] in Urine by Automated
68
508
1.50
1.95
2.9
2.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
20
107
1.96
1.94
2.8
4.1
%
0.5
1.1
—
10
21
(42870588) Differential panel, method unspecified - Blood
72
545
1.49
1.93
6.4
5.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
54
387
1.53
1.87
2.2
2.0
mg/l
3.0
2.6
0.74
48
333
(3019060) Gas panel - Arterial blood
10
40
2.58
1.86
2.0
5.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
53
379
1.53
1.85
6.8
3.0
ph
7.4
7.4
0.25
12
63
(3007853) Bacteria identified in Skin by Aerobe culture
28
171
1.74
1.82
2.5
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
101
827
1.43
1.77
3.6
2.7
estimate
0.0
0.0
0.00
23
150
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
18
3.40
1.76
2.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
18
3.40
1.76
2.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
18
3.40
1.76
2.0
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29
181
1.70
1.75
1.7
2.6
umol/l
3.5
4.9
2.33
19
158
(3016879) Cocaine [Presence] in Urine
19
104
1.91
1.74
1.5
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
13
3.91
1.72
4.0
3.0
mu/l
39.4
14.2
—
5
13
(40761536) Microorganisms panel - Urine sediment
22
128
1.80
1.68
4.9
2.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
25
2.86
1.66
1.1
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
38
258
1.58
1.66
3.4
2.1
e6/l
9.0
11.2
0.22
29
228
(3009261) Glucose [Presence] in Urine by Test strip
102
844
1.41
1.65
3.6
2.7
estimate
0.0
0.0
0.00
25
153
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
39
267
1.57
1.65
1.4
1.4
pmol/l
434.0
427.3
0.07
34
247
(3035637) Corticotropin [Mass/volume] in Plasma
6
20
3.06
1.59
1.3
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
54
400
1.47
1.59
2.1
1.5
mmol/l
1.4
1.4
0.15
46
375
(3027008) Opiates [Presence] in Urine
19
109
1.82
1.52
1.5
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
100
833
1.38
1.52
4.9
3.9
estimate
0.0
0.0
0.50
24
157
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
37
2.50
1.50
1.7
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
28
181
1.63
1.50
1.5
1.7
nmol/l
1061.0
1154.0
0.22
20
146
(3028300) Cannabinoids [Presence] in Urine
19
110
1.80
1.48
1.5
1.3
—
—
—
0
0
(4306422)
9
38
2.43
1.47
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
29
190
1.61
1.47
2.8
1.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
12
59
2.10
1.46
9.1
1.9
kpa
5.4
5.0
0.21
12
59
(3025159) Blasts/100 leukocytes in Blood
18
103
1.82
1.46
2.7
4.5
%
0.0
0.3
—
9
23
(3000764) Benzodiazepines [Presence] in Urine
19
111
1.78
1.45
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
16
3.17
1.44
1.4
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
16
3.17
1.44
1.6
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
167
1527
1.47
1.40
5.0
4.4
pmol/l
14.3
14.1
0.57
160
1465
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
29
2.46
1.40
2.0
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
7
29
2.46
1.40
1.7
1.3
ug/l
0.5
1.7
—
7
24
(3026389) Candida sp identified in Specimen by Organism specific culture
6
23
2.65
1.37
1.8
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
6
23
2.65
1.37
2.2
4.5
mmol/l
1.4
1.4
—
6
23
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
68
1.97
1.36
1.6
1.4
—
—
—
0
0
(3015736) pH of Urine
79
643
1.37
1.35
2.9
2.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
31
211
1.55
1.35
4.2
2.7
ng/l
4554.3
252.7
0.44
13
94
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
27
178
1.59
1.34
2.1
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
59
458
1.40
1.34
4.3
2.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
23
146
1.65
1.33
3.9
2.3
u/l
33.3
34.3
0.05
18
123
(3002582) Erythrocytes [#/volume] in Urine
50
378
1.42
1.32
4.0
2.2
e6/l
25.4
85.9
0.81
33
282
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
18
2.82
1.29
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
18
2.82
1.29
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
18
108
1.73
1.27
1.6
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
18
108
1.73
1.27
3.2
4.4
%
0.0
0.2
—
10
30
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
36
2.27
1.25
15.1
7.6
%
0.7
0.7
—
8
36
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
36
2.27
1.25
13.4
7.6
%
1.4
1.3
—
8
36
(3014007) Fractional oxyhemoglobin in Arterial blood
8
36
2.27
1.25
15.1
7.6
%
95.6
94.7
—
8
36
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
25
2.44
1.25
1.8
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
79
1.83
1.20
1.1
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
26
2.35
1.19
1.7
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
155
0.50
1.19
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
38
278
1.45
1.19
1.7
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
52
404
1.38
1.17
1.3
1.3
iu/ml
14.0
22.0
0.93
22
133
(3000494) Fungus identified in Specimen by Culture
27
185
1.53
1.16
1.7
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
20
2.54
1.16
1.8
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
138
0.49
1.14
1.0
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
189
1792
1.57
1.11
14.6
9.2
mg/l
15.2
16.2
0.22
162
1332
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
31
2.30
1.11
1.0
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
79
660
1.32
1.10
3.6
2.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
174
1626
1.42
1.08
4.7
3.2
mmol/l
6.0
5.5
4.32
162
1559
(3018095) Leukocytes [#/volume] in Urine
62
504
1.33
1.04
4.7
2.7
e6/l
23.9
35.3
0.36
39
312
(40768443) Skin Pathology biopsy report
10
53
1.93
1.03
1.6
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
21
140
1.56
1.02
2.2
4.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
35
261
1.41
1.00
4.7
3.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
49
1.87
1.00
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
52
415
1.34
0.99
4.5
2.8
estimate
0.0
0.0
0.80
24
158
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
36
1.98
0.98
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
174
1635
1.38
0.96
4.5
4.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
70
1.76
0.94
1.1
1.1
—
0.7
—
0
12
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
27
2.26
0.94
1.8
1.4
—
—
—
0
0
(3020891) Body temperature
6
28
2.18
0.92
9.5
3.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
53
429
1.32
0.91
1.6
1.3
g/l
2.5
2.1
1.12
35
270
(3009542) Hematocrit [Volume Fraction] of Blood
184
1749
1.43
0.91
15.4
10.5
%
40.3
39.9
0.37
153
1517
(3037522) Nuclear Ab [Titer] in Serum
41
323
1.34
0.85
1.5
1.4
titre
1360.0
501.4
—
9
69
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
32
243
1.37
0.84
1.5
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
6
32
1.90
0.82
1.0
1.7
mmol/l
8.5
6.8
—
6
26
(3019150) Specific gravity of Urine by Refractometry
44
353
1.31
0.81
3.2
2.7
kg/l
1.0
1.0
—
8
42
(1002224) Polysomnography panel
15
98
1.57
0.81
1.1
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
20
140
1.47
0.80
1.4
2.0
e9/l
4.9
4.3
0.42
15
122
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
20.3
—
1848.7
—
0
24
(3001019) Free T4 and TSH panel - Serum or Plasma
17
242
0.68
0.78
1.8
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
60
505
1.26
0.77
1.6
1.2
u/ml
0.5
2.2
1.21
16
134
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
38
1.87
0.74
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
58
1.58
0.71
3.3
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
77
1.59
0.70
1.5
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
39
315
1.29
0.69
1.3
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
42
1.69
0.69
11.1
1.9
%
1.3
1.3
—
7
42
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
180
1.38
0.69
3.2
2.0
e6/l
4.6
4.6
—
9
86
(4268621)
5
28
1.80
0.66
3.0
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
63
1.62
0.63
2.1
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
197
1916
1.49
0.62
15.7
8.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
50
1.62
0.62
1.5
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
12
80
1.53
0.61
3.0
2.9
mmol/l
1.2
1.2
0.27
12
72
(3020874) Milk IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.2
—
0
7
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
16.5
—
999.7
—
0
23
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
35
1.73
0.58
2.2
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
15
108
1.42
0.55
2.5
2.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
38
1.60
0.55
16.8
7.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
62
1.47
0.54
1.4
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
66
1.54
0.53
1.8
1.2
u/ml
2.1
1.9
—
5
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
40
1.51
0.52
3.3
2.1
%
13.7
13.2
—
6
40
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
15
110
1.39
0.50
1.6
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
46
1.54
0.49
1.1
2.2
—
—
—
0
0
(4010399)
14
102
1.40
0.48
1.0
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
66
588
1.18
0.48
1.8
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
30
247
1.25
0.47
4.1
2.1
mosm/kgh2o
540.3
559.6
0.18
24
219
(4034850)
7
48
1.47
0.47
8.0
7.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
21
165
1.30
0.47
1.8
2.0
u/ml
26.0
38.3
0.33
21
158
(3006315) Basophils [#/volume] in Blood
96
884
1.16
0.46
5.8
5.5
e9/l
0.0
0.0
0.67
81
778
(1761868) Lipid panel - Serum or Plasma
82
747
1.16
0.45
2.4
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
140
0.70
0.45
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
149
0.72
0.41
1.4
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
23.3
—
0
15
(3008037) Lactate [Moles/volume] in Venous blood
0
17
0.00
0.41
0.0
2.4
—
1.1
—
0
17
(3038515) Glucose [Moles/volume] in Venous blood
0
17
0.00
0.41
0.0
2.4
—
6.6
—
0
17
(3045424) Erythrocytes [Presence] in Urine
5
34
1.48
0.40
1.4
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
24
197
1.25
0.40
1.3
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
95
882
1.14
0.39
5.8
5.5
e9/l
0.6
0.5
1.99
81
781
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
0.4
—
0
5
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
180
0.76
0.38
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
233
0.80
0.37
2.1
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
107
1005
1.13
0.36
7.9
8.9
e9/l
4.4
3.9
1.43
93
883
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
71
1.28
0.36
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
77
0.64
0.36
2.0
1.3
nmol/l
0.5
0.4
—
5
61
(3002256) Pathology report gross observation
28
237
1.21
0.36
1.3
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
44
1.37
0.34
1.7
3.9
mmol/l
22.9
24.8
—
6
44
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
14
109
1.30
0.34
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
41
462
0.86
0.34
2.9
3.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
44
392
1.16
0.32
1.4
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
6
47
1.28
0.32
1.0
1.0
—
1.2
—
0
23
(3019198) Lymphocytes [#/volume] in Blood
97
912
1.12
0.31
5.8
5.5
e9/l
2.1
2.0
0.17
85
819
(3028707) Methadone [Presence] in Urine by Screen method
7
53
1.33
0.31
1.1
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
167
1.22
0.29
1.5
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
56
1.26
0.29
3.0
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
7
57
1.24
0.29
2.1
2.6
ng/l
54.1
77.0
—
7
51
(3002385) Erythrocyte distribution width [Ratio]
164
1593
1.14
0.28
16.7
11.6
%
13.5
13.5
0.02
164
1575
(40761535) Cells panel - Urine sediment
12
94
1.29
0.28
3.6
3.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
94
1.29
0.28
1.7
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
88
827
1.11
0.28
6.3
5.5
%
7.5
7.8
0.26
82
776
(3022096) Basophils/100 leukocytes in Blood
85
799
1.11
0.27
6.2
5.3
%
0.7
0.7
0.45
78
739
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
104
1.27
0.27
4.2
1.6
ml/min/173m2
70.3
87.7
—
7
42
(3003327) Ova and parasites identified in Stool by Light microscopy
11
86
1.29
0.26
1.3
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
90
850
1.10
0.26
5.7
5.1
%
57.5
56.8
0.25
82
798
(3011288) Drugs identified in Urine by Screen method
9
73
1.24
0.26
2.2
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
152
1.20
0.24
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
38
344
1.13
0.23
1.5
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
97
924
1.09
0.23
5.9
6.0
e9/l
0.2
0.2
1.77
86
830
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
79
1.28
0.22
1.9
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
90
855
1.09
0.22
6.1
5.3
%
28.3
29.8
0.79
82
802
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
40
1.26
0.22
1.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
107
1.23
0.22
1.7
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
39
355
1.12
0.22
3.9
2.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
42
1.20
0.21
1.0
1.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
87
827
1.09
0.21
6.3
5.3
%
2.9
2.7
0.34
79
772
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
109.7
—
0
11
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.1
—
93.8
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
12.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.1
—
103.6
—
0
5
(3035285) Chloride [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.3
—
105.5
—
0
11
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.1
—
121.1
—
0
11
(3041354) Potassium [Moles/volume] in Venous blood
0
11
0.00
0.21
0.0
2.3
—
3.9
—
0
11
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
173.5
—
0
10
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.6
—
372.6
—
0
10
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.5
—
1.2
—
0
10
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
30.0
—
0
10
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
1.0
—
0
10
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
44
405
1.11
0.21
1.3
1.3
u/ml
8.3
9.5
0.08
19
172
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
2.4
—
95.0
—
0
14
(3036071) Salmonella sp Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
86
819
1.09
0.20
2.1
1.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
90
1.23
0.19
1.9
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
63
595
1.08
0.18
2.0
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
69
1.17
0.16
1.5
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
78
746
1.07
0.16
10.3
7.1
e9/l
0.0
0.0
0.72
60
603
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
78
1.16
0.15
1.2
1.3
—
—
—
0
0
(4035726)
14
121
1.17
0.15
1.7
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
169
1.14
0.15
1.1
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
122
1.16
0.14
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
19
171
1.12
0.13
1.3
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
192
1.10
0.11
2.8
2.0
u/l
1156.0
2278.2
—
7
78
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
411
0.94
0.10
1.8
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
57
1.05
0.08
1.7
2.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
85
1.06
0.07
4.0
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
47
454
1.05
0.06
5.4
6.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
617
0.96
0.06
1.5
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
14
151
0.92
0.05
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
130
0.92
0.04
1.6
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
26
250
1.05
0.03
1.7
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
92
1.09
0.03
2.5
2.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
45
460
0.97
0.03
1.8
2.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
118
0.93
0.03
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
127
0.94
0.01
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
293
1.03
0.01
1.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
10
106
0.94
0.01
1.4
1.2
miu/ml
278.8
257.6
—
5
57
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
126
0.95
0.00
1.6
1.3
—
—
—
0
0
(3000492) Spirometry study
18
184
0.98
0.00
1.2
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
22
224
0.98
0.00
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
139
1.01
0.00
1.2
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
149
1.01
0.00
1.5
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
149
1.01
0.00
1.5
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
12
115
1.05
0.00
1.4
1.1
—
106.0
—
0
5
(3005033) Fetal Nuchal fold Thickness US
12
125
0.96
0.00
1.6
1.3
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
0.0
—
0
7
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
0.9
—
0
7
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
2.0
—
0
7
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
89
0.89
0.00
3.9
2.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
86.9
—
0
7
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
150
1.00
0.00
1.5
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
6.8
—
0
6
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
3.1
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
150
1.00
0.00
1.5
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
51
0.98
0.00
1.4
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
51
0.98
0.00
1.2
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
75
0.93
0.00
1.4
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
59
0.84
0.00
1.2
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint O15_PREECLAMPS_CHRONIC_HYPERT and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have O15_PREECLAMPS_CHRONIC_HYPERT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: O15_PREECLAMPS_CHRONIC_HYPERT – Pre-eclampsia superimposed on chronic hypertension
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data